Earth Science Tech, Inc. (ETST) — AI Stock Analysis

Earth Science Tech, Inc. is a biotechnology company focused on developing and delivering nutraceuticals, bioceuticals, and dietary supplements. The company targets health, wellness, nutrition, supplement, cosmetic, and alternative medicine markets worldwide.

Company Overview

TL;DR:

Earth Science Tech, Inc. operates in the healthcare sector, focusing on nutraceuticals and dietary supplements for various health conditions. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company distributes its products through retail, clinics, pharmacies, and online channels, competing in a fragmented market.

About ETST

Earth Science Tech, Inc. (ETST) is a biotechnology company that develops, markets, and distributes nutraceuticals, bioceuticals, and dietary supplements. Founded in 2010 and formerly known as Ultimate Novelty Sports, Inc., the company rebranded in March 2014 to focus on health and wellness products. Headquartered in Doral, Florida, ETST offers a range of products targeting chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company's product portfolio includes hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. These are available in various formulations such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, and powders. ETST distributes its products through multiple channels, including its retail store, clinics, pharmacies, and online platforms. This multi-channel approach aims to maximize market reach and cater to diverse customer preferences. ETST also provides medical equipment and devices, further diversifying its offerings within the healthcare sector. The company operates with 32 employees and aims to expand its market presence through innovative product development and strategic distribution partnerships.

Investment Thesis

Earth Science Tech, Inc. presents a speculative investment opportunity within the nutraceutical and dietary supplement market. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company's valuation reflects both its growth potential and inherent risks associated with OTC-listed companies. A gross margin of 65.1% indicates strong pricing power, while a profit margin of 10.0% demonstrates profitability. Growth catalysts include expanding its online presence and developing new formulations for existing products. However, potential risks include the company's reliance on a limited product line and the competitive nature of the nutraceutical market. The company's high beta of 2.02 suggests significant volatility, making it suitable for investors with a high-risk tolerance. The lack of dividend yield further emphasizes its growth-oriented profile.

Industry Context

Earth Science Tech, Inc. operates within the growing nutraceutical and dietary supplement industry. This market is characterized by increasing consumer awareness of health and wellness, driving demand for natural and alternative health solutions. The industry is highly competitive, with numerous players ranging from large pharmaceutical companies to smaller, specialized firms. ETST competes with companies offering similar products, focusing on specific health conditions and distribution channels. The global nutraceutical market is expected to continue growing, driven by aging populations and rising healthcare costs.

Drug Manufacturers - Specialty & Generic

Healthcare

Growth Opportunities

Expanding Online Presence: ETST can capitalize on the growing e-commerce trend by enhancing its online platform and digital marketing efforts. The global e-commerce market is projected to reach trillions of dollars in the coming years, offering a significant opportunity for ETST to increase its sales and market reach. By investing in SEO, social media marketing, and targeted advertising, ETST can attract new customers and drive online sales, with an expected impact within the next 1-2 years.
Developing New Formulations: ETST can invest in research and development to create new and innovative formulations for its existing products. The nutraceutical industry is constantly evolving, with new ingredients and delivery methods emerging regularly. By staying ahead of the curve and developing unique and effective formulations, ETST can differentiate itself from competitors and attract health-conscious consumers. This could lead to new product launches within the next 18-24 months.
Strategic Partnerships: ETST can form strategic partnerships with clinics, pharmacies, and healthcare providers to expand its distribution network and reach a wider audience. Collaborating with established healthcare professionals can enhance ETST's credibility and build trust with consumers. These partnerships could be established within the next year, leading to increased sales and market penetration.
Geographic Expansion: ETST can explore opportunities to expand its operations into new geographic markets, particularly in regions with a growing demand for nutraceuticals and dietary supplements. Emerging markets in Asia and Latin America offer significant growth potential. By conducting market research and adapting its products to local preferences, ETST can successfully enter new markets and diversify its revenue streams over the next 2-3 years.
Focus on Specific Health Conditions: ETST can focus its marketing efforts on specific health conditions, such as chronic pain, joint pain, and inflammation. By targeting consumers with specific health needs, ETST can increase its brand awareness and build a loyal customer base. This targeted approach can be implemented within the next 6-12 months, leading to improved marketing ROI and increased sales.

Market capitalization of $0.03 billion indicates a small-cap company with potential for growth but also higher risk.
P/E ratio of 9.88 suggests the company is potentially undervalued compared to its earnings.
Gross margin of 65.1% reflects strong pricing power and efficient cost management.
Profit margin of 10.0% demonstrates the company's ability to generate profit after all expenses.
Beta of 2.02 indicates high volatility compared to the market, suggesting higher risk and potential reward.

What They Do

Develops and markets nutraceuticals and bioceuticals.
Offers dietary supplements for various health conditions.
Provides products targeting chronic pain, joint pain, and inflammation.
Distributes hemp oils, vitamins, minerals, and herbs.
Sells personal care products, homeopathies, and functional foods.
Offers medical equipment and devices.

Business Model

Develops and manufactures nutraceutical and dietary supplement products.
Distributes products through retail stores, clinics, pharmacies, and online channels.
Generates revenue through the sale of its products to consumers and healthcare providers.

Individuals seeking natural health and wellness solutions.
Patients with chronic pain, joint pain, and inflammation.
Healthcare providers recommending supplements to their patients.
Consumers interested in vitamins, minerals, and herbal remedies.

Proprietary formulations and unique product offerings.
Established distribution network through multiple channels.
Brand recognition and customer loyalty in specific market segments.

Catalysts

Upcoming: Potential new product launches in the nutraceutical and dietary supplement market.
Ongoing: Expansion of online presence and e-commerce sales channels.
Ongoing: Strategic partnerships with clinics, pharmacies, and healthcare providers.

Risks

Potential: Intense competition from larger and more established companies in the nutraceutical industry.
Potential: Changing regulations and compliance requirements affecting the dietary supplement market.
Potential: Fluctuations in raw material prices impacting the company's profitability.
Ongoing: Limited financial resources and small market capitalization.
Ongoing: High beta indicating significant price volatility.

Strengths

Diverse product line targeting various health conditions.
Multi-channel distribution network.
Strong gross margin indicating pricing power.
Focus on natural and alternative health solutions.

Weaknesses

Small market capitalization and limited financial resources.
High beta indicating significant volatility.
Reliance on a limited number of key products.
Limited brand recognition compared to larger competitors.

Opportunities

Expanding online presence and e-commerce sales.
Developing new and innovative product formulations.
Forming strategic partnerships with healthcare providers.
Entering new geographic markets with growing demand for nutraceuticals.

Threats

Intense competition from larger and more established companies.
Changing regulations and compliance requirements.
Fluctuations in raw material prices.
Negative publicity or adverse events affecting the nutraceutical industry.

Competitors & Peers

Delivra Corp. — Focuses on topical delivery of active ingredients. — (DBCCF)
Dixie Brands, Inc. — Specializes in cannabis-infused products. — (DXBRF)
Flora Growth Corp. — Focuses on cannabis cultivation and product development. — (FLOOF)
Inspirato Incorporated — Luxury travel subscription service, unrelated to ETST's core business. — (INIS)
Milestone Brands Inc. — Focuses on brand development and distribution in the beverage industry, unrelated to ETST's core business. — (MILFF)

Key Metrics

Volume: 0
MoonshotScore: 61/100

Company Profile

CEO: Giorgio R. Saumat
Headquarters: Miami, US
Employees: 32
Founded: 2014

AI Insight

AI analysis pending for ETST

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Earth Science Tech, Inc. do?

Earth Science Tech, Inc. is a biotechnology company focused on developing, marketing, and distributing nutraceuticals, bioceuticals, and dietary supplements. The company offers a range of products targeting various health conditions, including chronic pain, joint pain, inflammation, and overall wellness. These products are available in various formulations and are distributed through retail stores, clinics, pharmacies, and online channels.

What do analysts say about ETST stock?

As of 2026-03-17, there is no available analyst coverage for Earth Science Tech, Inc. due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks, including limited liquidity and potential volatility. Key valuation metrics include a P/E ratio of 9.88 and a gross margin of 65.1%.

What are the main risks for ETST?

The main risks for Earth Science Tech, Inc. include intense competition from larger companies, changing regulations in the nutraceutical industry, fluctuations in raw material prices, limited financial resources, and high price volatility. As an OTC-listed company, ETST also faces risks related to limited liquidity, potential for manipulation, and reduced regulatory oversight. Investors should carefully consider these risks before investing.

Is ETST a good investment right now?

Use the AI score and analyst targets on this page to evaluate Earth Science Tech, Inc. (ETST). Our analysis considers fundamentals, technicals, and market sentiment to help you decide.

What is the MoonshotScore for ETST?

The MoonshotScore is a proprietary 0-100 AI rating that evaluates Earth Science Tech, Inc. across multiple dimensions including financial health, growth trajectory, and risk factors.

Where can I find ETST financial statements?

Earth Science Tech, Inc. financial data including revenue, earnings, and balance sheet metrics are available in the Financials tab on this page, sourced from institutional-grade data providers.

What do analysts say about ETST?

Analyst consensus targets and ratings for Earth Science Tech, Inc. are shown in the analysis section. These are aggregated from major Wall Street firms and updated regularly.

How volatile is ETST stock?

Check the beta and historical price range on this page to assess Earth Science Tech, Inc.'s volatility relative to the broader market.